Release Date: 18/01/22 09:38 Summary: December Quarterly Activities Report Price Sensitive: Yes Download Document 704.42KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%